We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-10.14%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$870M
AUM Growth
-$39.8M
Cap. Flow
+$14.2M
Cap. Flow %
1.63%
Top 10 Hldgs %
40.06%
Holding
178
New
29
Increased
43
Reduced
37
Closed
47

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$24.2M
2
NEWR
New Relic, Inc.
NEWR
+$16M
3
CMRC
Commerce.com Inc Series 1
CMRC
+$12.8M
4
BBWI icon
Bath & Body Works
BBWI
+$12.8M
5
T icon
AT&T
T
+$10.7M

Top Sells

Rank Stock Value
1
PAE
PAE Incorporated Class A Common Stock
PAE
+$18.6M
2
CHGG icon
Chegg
CHGG
+$18.2M
3
AIR icon
AAR Corp
AIR
+$14.7M
4
WTW icon
Willis Towers Watson
WTW
+$11.1M
5
TMX
Terminix Global Holdings, Inc.
TMX
+$7.72M

Sector Composition

Rank Sector Weight
1 Technology 23.32%
2 Communication Services 13.99%
3 Healthcare 12.23%
4 Industrials 12.21%
5 Consumer Staples 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
101
CytomX Therapeutics
CTMX
$690M
$509K 0.06%
190,600
+45,600
+31% +$175K
GIII icon
102
G-III Apparel Group
GIII
$1.54B
$509K 0.06%
+18,819
New +$512K
VGII.U
103
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
$496K 0.06%
50,000
– –
RKTA.U
104
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$493K 0.06%
50,000
– –
LYRA
105
DELISTED
LYRA THERAPEUTICS INC
LYRA
$482K 0.06%
2,398
+1,101
+85% +$242K
TSAT icon
106
Telesat
TSAT
$524M
$465K 0.05%
28,193
+200
+0.7% +$4.46K
APSG.WS
107
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$461K 0.05%
336,425
– –
FIS icon
108
Fidelity National Information Services
FIS
$24.2B
$442K 0.05%
4,404
-59,342
-93% -$6.21M
QSI icon
109
Quantum-Si Incorporated
QSI
$153M
$433K 0.05%
92,468
+12,988
+16% +$63.3K
CC icon
110
Chemours
CC
$2.48B
$428K 0.05%
13,602
– –
RCEL icon
111
Avita Medical
RCEL
$137M
$427K 0.05%
50,343
– –
LNSR icon
112
LENSAR
LNSR
$64.5M
$392K 0.05%
52,950
– –
ROSS.U
113
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
$363K 0.04%
36,565
– –
VATE icon
114
INNOVATE Corp
VATE
$106M
$291K 0.03%
7,876
+1,140
+17% +$42.3K
HUGS.WS
115
DELISTED
USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
HUGS.WS
$286K 0.03%
253,233
+3,887
+2% +$4.34K
ROIVW
116
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$281K 0.03%
318,791
-35,161
-10% -$44.7K
SIOX
117
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$263K 0.03%
392,691
+174,185
+80% +$148K
PAYO icon
118
Payoneer
PAYO
$2.41B
$239K 0.03%
53,522
-51,050
-49% -$258K
VLN.WS
119
DELISTED
Valens Semiconductor Ltd Warrants
VLN.WS
$191K 0.02%
323,357
-30,175
-9% -$15.4K
PSFE icon
120
Paysafe
PSFE
$443M
$173K 0.02%
4,251
+2,958
+229% +$122K
AMBP.WS
121
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$154K 0.02%
96,253
-72,121
-43% -$137K
NSTB.WS
122
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$107K 0.01%
252,297
– –
AUS.WS
123
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$107K 0.01%
+195,057
New +$124K
AVPT icon
124
AvePoint
AVPT
$2.76B
$100K 0.01%
18,975
-10,100
-35% -$57.8K
PLXP
125
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$96K 0.01%
+23,844
New +$131K
3 4
5
6 7

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Clearline Capital held 178 positions worth $870M, down 4.4% from $910M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Clearline Capital's Q1 2022 filing shows 29 new, 43 increased, 37 reduced and 47 closed positions. Its largest new stake was Meta Platforms (Facebook): 96,971 shares worth $21.6M. The largest sale was PAE Incorporated Class A Common Stock, an estimated $18.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Communication Services and Healthcare.

  • Clearline Capital's largest Q1 2022 buy was Meta Platforms (Facebook): 96,971 shares worth $21.6M.
  • Clearline Capital added most to Array Technologies in Q1 2022, an estimated $9.35M increase.
  • Clearline Capital's biggest Q1 2022 reduction was Willis Towers Watson, cutting an estimated $11.1M.
  • Clearline Capital fully exited PAE Incorporated Class A Common Stock in Q1 2022, selling an estimated $18.6M.
  • Clearline Capital's ten largest holdings make up 40% of its $870M portfolio in Q1 2022.
  • Clearline Capital opened 29 new positions and closed 47 in Q1 2022.
  • Clearline Capital's portfolio value fell 4.4% quarter-over-quarter to $870M.

Based on Clearline Capital's 13F filing for Q1 2022, filed 16 May 2022.